Novocure Ltd (NYSE: NVCR) — Healthcare · Share Price, Chart & Market Data
About: NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
Sector: Healthcare
Industry: Medical Devices
Latest price: $12.44 (-0.24%)
NVCRNovocure Ltd
Loading watchlist status…
Trade NVCR now
Novocure Ltd share price
NVCR price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:34 pm GMT+0
NVCR price performance
1.717%
5D
13.4%
1M
-5.183%
YTD
-32.059%
1Y
NVCR price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:34 pm GMT+0
NVCR details
NVCR Market Signals